Your browser doesn't support javascript.
loading
Peak absolute lymphocyte count after CAR-T infusion predicts clinical response in aggressive lymphoma.
Bansal, Radhika; Novo, Mattia; Al Saleh, Abdullah S; Guerrico, Anatilde Gonzalez; Zhang, Henan; Shao, Zuoyi; Babadi, Elham; Martinez, Kodi E; McCoy, Gabrielle A; Hathcock, Matthew A; Khurana, Arushi; Bennani, Nabila Nora; Paludo, Jonas; Wang, Yucai; Ansell, Stephen M; Johnston, Patrick B; Villasboas, Jose C; Lin, Yi.
Affiliation
  • Bansal R; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Novo M; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Al Saleh AS; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Guerrico AG; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Zhang H; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Shao Z; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Babadi E; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Martinez KE; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • McCoy GA; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hathcock MA; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Khurana A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Bennani NN; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Paludo J; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Wang Y; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Ansell SM; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Johnston PB; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Villasboas JC; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Lin Y; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol ; 97(7): E241-E244, 2022 07.
Article in En | MEDLINE | ID: mdl-35385152

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Receptors, Chimeric Antigen Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Hematol Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Receptors, Chimeric Antigen Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Hematol Year: 2022 Type: Article Affiliation country: United States